Breaking News

A bellwether moment for a gene therapy; Uber's pilot of free rides to prenatal appointments

April 17, 2023
In a Columbus, Ohio, lab, a senior scientist at Sarepta Therapeutics looks at immunofluorescence images of the muscle fibers of a patient treated with the company's experimental gene therapy.
Maddie McGarvey for STAT

STAT+ | A bellwether moment: Once a distant dream, gene therapy for Duchenne nears historic decision

A looming verdict on Sarepta's therapy has made this perhaps the most consequential moment in the history of Duchenne.

By Jason Mast and Adam Feuerstein


STAT+ | Why do some blood stem cells go rogue? Study offers clue and possible target

Many people have blood cell clones that have the potential to turn cancerous. A specific DNA change is now identified as a key.

By Angus Chen


Free Uber rides helped patients keep their prenatal appointments. Now the company wants insurers to pay for it

Using a consumer app like Uber could make the process of organizing and taking rides to a clinic easier both for staff and patients.

By Mohana Ravindranath



A man holds a Narcan sample at a training session at a health department office in Queens, N.Y.
KENA BETANCUR/AFP via Getty Images

Opinion: OTC naloxone is a baby step toward making the life-saving medication accessible

Now that naloxone will be available OTC, we need more substantial efforts to reduce cost and increase access to this lifesaving medication.

By Jonathan JK Stoltman and Mishka Terplan


Q&A: What does it mean when a clinical trial is delayed? More than you think

STAT sat down with clinical trials expert Frank David to talk about why trial delays are important and how trials have changed over time.

By Erica Goode


Opinion: Where are the guidelines for the production of animals with intentional genomic alterations?

The public should not have to settle for reading regulatory tea leaves when it comes to animals with intentional genomic alterations.

By Peter G. Lurie and Beth Ellikidis


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments